Strategies for Organic Drug Synthesis and Design

DANIEL LEDNICER has devoted his career in both the private and public sectors to the search for new therapeutic agents. A former chemist and project officer at the National Cancer Institute, he has held the positions of director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. He is the editor of the Wiley series The Organic Chemistry of Drug Synthesis.

Prostaglandins, Protease Inhibitors, and Retinoids.; Drugs Based on a Substituted Benzene Ring.; Indenes, Naphthalenes, and Other Polycyclic Aromatic Compounds.; Steroids: Part 1: Estranes, Gonanes, and Androstanes.; Steroids: Part 2: Compounds Related to Progesterone and Cortisone.; Nonsteroidal Estrogens and Their Antagonists.; Opioid Analgesics.; Drugs Based on Five--Membered Heterocycles.; Drugs Based on Six--Membered Heterocycles.; Five--Membered Heterocycles Fused to a Benzene Ring.; Six--Membered Heterocycles Fused to a Benzene Ring.; Seven--Membered Heterocyclic Rings Fused to Benzene.; Heterocycles Fused to Two Benzene Rings.; Beta--Lactam Antibiotics.; Heterocycles Fused to Other Heterocyclic Rings.; Cross Index of Compounds.; Indexes.